Closing the gap between alcoholism research and practice: The case for pharmacotherapy

Psychiatric Services

Volumn 47, Issue 9, 1996, Pages 917-920

  Meza, Eduardo ^a   Kranzler, Henry R ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BUSPIRONE; DISULFIRAM; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; IMIPRAMINE; NALTREXONE; NARCOTIC ANTAGONIST; NEUROLEPTIC AGENT; ONDANSETRON; PLACEBO; RITANSERIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALCOHOLISM; ANXIETY NEUROSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG APPROVAL; DRUG INDUCED DISEASE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REVIEW; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

EID: 0029744763     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.47.9.917     Document Type: Review

References (48)

1. Gordis E: Alcohol research: at the cutting edge. Archives of General Psychiatry 53: 199-201, 1996
2. Naranjo CA, Bremner KF: Dissemination of research results regarding the pharmacotherapy of substance abuse: case examples and critical review. Substance Abuse 17:39-50, 1996
3. Epstein EE, McCrady BS: Research on the nature and treatment of alcoholism: does one inform the other? Journal of Consulting and Clinical Psychology 62:1091-1095, 1994
4. Practice Guideline for the Treatment of Patients With Substance Use Disorders: Alcohol, Cocaine, Opioids. American Journal of Psychiatry 152(Nov suppl):1-59, 1995
5. Persons JB, Thase ME, Crits-Cristoph P: The role of psychotherapy in the treatment of depression: review of two practice guidelines. Archives of General Psychiatry 53: 283-290, 1996
6. Tabakoff B, Hoffman PL: Alcohol: neurobiology, in Substance Abuse: A Comprehensive Textbook. Baltimore, Williams & Wilkins, 1992
7. Coccaro EF, Murphy DL (eds): Serotonin in Major Psychiatric Disorders. Washington, DC, American Psychiatric Press, 1990
8. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: clinical evidence. Biological Psychiatry 36:326-337, 1994
9. Gianoulakis C: Endogenous opioids and excessive alcohol consumption. Journal of Psychiatry and Neuroscience 18:148-156, 1993
10. DiChiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proceedings of the National Academy of Sciences 85:5274-5278, 1988
11. Krystal JH, Webb E, Cooney N, et al: Specificity of ethanol-like effects elicited by serotonergic and noradrenergic mechanisms. Archives of General Psychiatry 51: 898-911, 1994
12. Krystal JH, Webb E, Cooney N, et al: Serotonergic and noradrenergic dysregulation in alcoholism: meta-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. American Journal of Psychiatry 153:83-92, 1996
13. Tsai G, Gastfriend DR, Coyle JT: The glutamatergic basis of human alcoholism. American Journal of Psychiatry 152:332-340, 1995
14. Anton RF, Kranzler HR, Meyer RE: Neurobehavioral aspects of the pharmacotherapy of alcohol dependence. Clinical Neuroscience 3:145-154, 1995
15. Meyer RE: Prospects for a rational pharmacotherapy of alcoholism. Journal of Clinical Psychiatry 50:403-412, 1989
16. Kranzler HR, Anton RF: Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. Journal of Consulting and Clinical Psychology 62:1116-1126, 1994
17. Sellers EM, Naranjo CA, Peachey JE: Drugs to decrease alcohol consumption. New England Journal of Medicine 305: 1255-1262, 1981
18. Anton RF: New directions in the pharmacotherapy of alcoholism. Psychiatric Annals 25:353-361, 1995
19. Bohn MJ: Alcoholism. Psychiatric Clinics of North America 16:679-692, 1993
20. Ulm RR, Volpicelli JR, Volpicelli LA: Opiates and alcohol self-administration in animals. Journal of Clinical Psychiatry 56 (suppl 7):5-14, 1995
21. Froehlich JC: Genetic factors in alcohol self-administration. Journal of Clinical Psychiatry 56:(suppl 7):15-23, 1995
22. Hald J, Jacobsen E: A drug sensitizing the organism to ethyl alcohol. Lancet 255:1001, 1948
23. Barrera SE, Osinski WA, Davidoff E: The use of antabuse (tetraethylthiuram-disulphide) in chronic alcoholics. American Journal of Psychiatry 107:8-13, 1950
24. Volpicelli JR, Alterman AI, Hayashida M, et al: Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry 49:875-880, 1992
25. O'Malley SS, Jaffe AJ, Chang G, et al: Naltrexone and coping skills therapy for alcohol dependence. Archives of General Psychiatry 49:881-887, 1992
26. Swift RM, Whelihan W, Kuznetsov O, et al: Naltrexone-induced alterations in human ethanol intoxication. American Journal of Psychiatry 151:1463-1467, 1994
27. Volpicelli JR, Watson NT, King AC, et al: Effect of naltrexone on alcohol "high" in alcoholics. American Journal of Psychiatry 152:613-615, 1995
28. O'Malley SS, Jaffe AJ, Rode S, et al. Experience of a "slip" among alcoholics treated with naltrexone or placebo. American Journal of Psychiatry 153:281-283, 1996
29. Jaffe AJ, Rounsaville B, Chang G, et al: Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching, Journal of Consulting and Clinical Psychology, in press
30. O'Malley SS, Jaffe AJ, Chang G, et al: Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry 53:217-224, 1996
31. Bonn MJ, Kranzler HR, Beazoglou D, et al: Naltrexone and brief counseling to reduce heavy drinking: results of a small clinical trial. American Journal on Addictions 3:91-99, 1994
32. Mason BJ, Ritvo FC, Morgan RO, et al: A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCL for alcohol dependence. Alcoholism: Clinical and Experimental Research 18:1162-1167, 1994
33. Naranjo CA, Sellers EM, Lawrin MO: Modulation of ethanol intake by serotonin uptake inhibitors. Journal of Clinical Psychiatry 47(Apr suppl): 16-22, 1986
34. Gorelick DA, Paredes A: Effect of fluoxetine on alcohol consumption in male alcoholics. Alcoholism: Clinical and Experimental Research 16:261-255, 1992
35. Cornelius JR, Salloum IM, Cornelius MD, et al: Fluoxetine trial in suicidal depressed alcoholics. Psychopharmacology Bulletin 29:195-199, 1993
36. Cornelius JR, Salloum IM, Ehler JG, et al: Double-blind fluoxetine in depressed alcoholics. Presented at the annual meeting of the American Psychiatric Association, New York, May 4-9, 1996
37. Kranzler HR, Burleson JA, Korner P, et al: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. American Journal of Psychiatry 152: 391-397, 1995
38. Kranzler HR, Burleson JA, Del Boca FK, et al: Buspirone treatment of anxious alcoholics: a placebo-controlled trial. Archives of General Psychiatry 51:720-731, 1994
39. Ciraulo DA, Jaffe JH: Tricyclic antidepressants in the treatment of depression associated with alcoholism. Journal of Clinical Psychopharmacology 1:146-150, 1981
40. Nunes EV, McGrath PJ, Quitkin FM, et al: Imipramine treatment of alcoholism with comorbid depression. American Journal of Psychiatry 150:963-965, 1993
41. McGrath PJ, Nunes EV, Stewart JW, et al: Imipramine treatment of alcoholics with primary depression. Archives of General Psychiatry 53:232-240, 1996
42. Mason BJ, Kocsis JH, Ritvo EC, et al: A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA 275:761-767, 1996
43. O'Malley SS: Psychosocial treatments for drug abuse, in Research in Substance Abuse. Edited by Stefanis C, Hippius H, Naber D. Toronto, Hogrefe & Huber, 1995
44. Miller WR, McCrady BS: The importance of research on Alcoholics Anonymous, in Research on Alcoholics Anonymous: Opportunities and Alternatives. Edited by McCrady BS, Miller WR. New Brunswick, NJ, Rutgers Center of Alcohol Studies, 1993
45. Institute of Medicine: Prevention and Treatment of Alcohol Problems: Research Opportunities. Washington, DC, National Academy Press, 1990
46. Galaif ER, Sussman S: For whom does Alcoholics Anonymous work? International Journal of the Addictions 30:161-184, 1995
47. Alcoholics Anonymous: The AA Member: Medications and Other Drills: A Report From a Group of Physicians in AA. New York, Alcoholics Anonymous World Services, 1984
48. McLellan AT, Arndt IO, Metzger DS, et al: The effects of psychosocial services in substance abuse treatment. JAMA 269:1953-1959, 1993